Meeting CoverageMultimediaNon-ASH Meetings Evaluating New Myeloma Agent Combinations in Lenalidomide-Refractory Patients Saturday, June 2, 2018 Dr. Chari reports results from a trial of daratumumab plus carfilzomib-dexamethasone in patients with lenalidomide-refractory disease.